Literature DB >> 25798373

Treatment adherence and transitioning youth in pediatric multiple sclerosis.

Sabeen Lulu1, Laura Julian, Emma Shapiro, Kyr Hudson, Emmanuelle Waubant.   

Abstract

BACKGROUND: Transitioning youth with multiple sclerosis (MS) represent a vulnerable group to potentially poor outcomes. It is unknown how pediatric MS patients transition into adult care.
OBJECTIVES: To describe self-management skills that include adherence to disease-modifying therapies, quality of life measures, illness perception, transition readiness and healthcare skills assessments in patients with pediatric MS and associations with clinical and cognitive outcomes.
METHODS: This is a prospective cross-sectional study at the pediatric MS center and transitional MS clinic at the University of California, San Francisco. Patients and one of their parents completed validated surveys for self-management skills. Non-adherence is defined as not taking their medication more than 20% of the time in the past 1 month. Wilcoxin matched-pairs rank test and McNemar's tests were used for comparison of patient and parent responses. Univariate and multivariate regression models were used for analyses adjusting for disease duration and socio-economic status.
RESULTS: Thirty patients were enrolled with a mean (+/-SD) age of 15.8 years+/-2.8, 53% was female and 47% Hispanic. The rate of non-adherence was 37%. The most common reason for non-adherence was forgetting to take their medication reported in 50% of patients. In adjusted regression models, higher EDSS was associated with a lower score on patient's quality of life (13 points decrease, 95% CI 6–18, p<0.0001), and lower healthcare skills (15 points decrease, 95% CI5–26, p=0.006). Four points increase in Symbol Digit Modalities Test score was associated a 0.1 increase in transition readiness score (95% CI0.07–0.2, p=0.001) and 3.9 points increase in health care skills scores (95% CI 1.7–6, p=0.008).

Entities:  

Mesh:

Year:  2014        PMID: 25798373      PMCID: PMC4361811          DOI: 10.1016/j.msard.2014.09.088

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  22 in total

1.  The brief illness perception questionnaire.

Authors:  Elizabeth Broadbent; Keith J Petrie; Jodie Main; John Weinman
Journal:  J Psychosom Res       Date:  2006-06       Impact factor: 3.006

2.  Optimal recall period and response task for self-reported HIV medication adherence.

Authors:  Minyi Lu; Steven A Safren; Paul R Skolnik; William H Rogers; William Coady; Helene Hardy; Ira B Wilson
Journal:  AIDS Behav       Date:  2007-06-19

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Socioeconomic status and childhood asthma in urban minority youths. The GALA II and SAGE II studies.

Authors:  Neeta Thakur; Sam S Oh; Elizabeth A Nguyen; Melissa Martin; Lindsey A Roth; Joshua Galanter; Christopher R Gignoux; Celeste Eng; Adam Davis; Kelley Meade; Michael A LeNoir; Pedro C Avila; Harold J Farber; Denise Serebrisky; Emerita Brigino-Buenaventura; William Rodriguez-Cintron; Rajesh Kumar; L Keoki Williams; Kirsten Bibbins-Domingo; Shannon Thyne; Saunak Sen; Jose R Rodriguez-Santana; Luisa N Borrell; Esteban G Burchard
Journal:  Am J Respir Crit Care Med       Date:  2013-11-15       Impact factor: 21.405

5.  Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report.

Authors:  Jared M Bruce; Laura M Hancock; Sharon G Lynch
Journal:  Mult Scler       Date:  2009-12-07       Impact factor: 6.312

6.  Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine.

Authors:  R W Blum; D Garell; C H Hodgman; T W Jorissen; N A Okinow; D P Orr; G B Slap
Journal:  J Adolesc Health       Date:  1993-11       Impact factor: 5.012

7.  The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis.

Authors:  V Devonshire; Y Lapierre; R Macdonell; C Ramo-Tello; F Patti; P Fontoura; L Suchet; R Hyde; I Balla; E M Frohman; B C Kieseier
Journal:  Eur J Neurol       Date:  2011-01       Impact factor: 6.089

8.  Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence.

Authors:  Francesco Patti
Journal:  Patient Prefer Adherence       Date:  2010-02-04       Impact factor: 2.711

9.  Natural history of multiple sclerosis with childhood onset.

Authors:  Christel Renoux; Sandra Vukusic; Yann Mikaeloff; Gilles Edan; Michel Clanet; Bénédicte Dubois; Marc Debouverie; Bruno Brochet; Christine Lebrun-Frenay; Jean Pelletier; Thibault Moreau; Catherine Lubetzki; Patrick Vermersch; Etienne Roullet; Laurent Magy; Marc Tardieu; Samy Suissa; Christian Confavreux
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

10.  Factors associated with adherence to treatment in children and adolescents with chronic rheumatic diseases.

Authors:  Vanessa M Bugni; Luciana S Ozaki; Karine Y K Okamoto; Cássia M P L Barbosa; Maria Odete E Hilário; Cláudio A Len; Maria Teresa Terreri
Journal:  J Pediatr (Rio J)       Date:  2012 Nov-Dec       Impact factor: 2.197

View more
  11 in total

1.  A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study.

Authors:  A Ghezzi; A Bianchi; D Baroncini; A Bertolotto; S Malucchi; V Bresciamorra; R Lanzillo; N Milani; V Martinelli; F Patti; C Chisari; M Rottoli; M Simone; D Paolicelli; A Visconti
Journal:  Neurol Sci       Date:  2017-08-22       Impact factor: 3.307

2.  Long-term fingolimod treatment in two pediatric patients with multiple sclerosis.

Authors:  Giovanna Borriello; Carlo Pozzilli
Journal:  Neurol Sci       Date:  2021-03-10       Impact factor: 3.307

Review 3.  Pediatric Acquired Demyelinating Disorders.

Authors:  J Nicholas Brenton
Journal:  Continuum (Minneap Minn)       Date:  2022-08-01

Review 4.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 5.  Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis.

Authors:  Marisa McGinley; Ian T Rossman
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 6.  Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis.

Authors:  Gabrielle Macaron; Jenny Feng; Manikum Moodley; Mary Rensel
Journal:  Curr Treat Options Neurol       Date:  2019-09-27       Impact factor: 3.972

Review 7.  Improving Outcomes in Pediatric Multiple Sclerosis: Current and Emerging Treatments.

Authors:  Colin Wilbur; E Ann Yeh
Journal:  Paediatr Drugs       Date:  2019-06       Impact factor: 3.930

8.  An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug.

Authors:  Michael Munsell; Molly Frean; Joseph Menzin; Amy L Phillips
Journal:  Patient Prefer Adherence       Date:  2016-12-30       Impact factor: 2.711

Review 9.  Needs and Experiences of Children and Adolescents with Pediatric Multiple Sclerosis and Their Caregivers: A Systematic Review.

Authors:  Shashank Ghai; Elisabeth Kasilingam; Roberta Lanzillo; Masa Malenica; Vincent van Pesch; Niamh Caitlin Burke; Antonio Carotenuto; Rebecca Maguire
Journal:  Children (Basel)       Date:  2021-05-25

Review 10.  MS in self-identified Hispanic/Latino individuals living in the US.

Authors:  Lilyana Amezcua; Jorge R Oksenberg; Jacob L McCauley
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.